Target intelligence / Profile preview

Urine excretion

Molecular classification
Physiological Process
01

Overview

Urine excretion is the systemic physiological process by which the kidneys eliminate metabolic waste products and maintain internal fluid and electrolyte homeostasis (National Center for Biotechnology Information [NCBI], 2023). It is not a discrete molecular target like a receptor or enzyme; instead, it represents the functional output of complex renal mechanisms including glomerular filtration, tubular reabsorption, and tubular secretion (StatPearls, 2023). In a pharmacological context, urine excretion is frequently used as a clinical endpoint or a pharmacodynamic biomarker to assess the efficacy of drugs like diuretics or SGLT2 inhibitors (PubMed, 2022). These drugs do not bind to 'excretion' itself but rather target specific proteins such as ion transporters or water channels within the nephron to modulate the volume and composition of urine (American Journal of Kidney Diseases, 2021). Because it is a macroscopic physiological process involving numerous molecular pathways, labeling it as a single therapeutic target is technically incorrect for drug discovery purposes. Monitoring urine excretion is vital for managing patients with cardiovascular and renal diseases to prevent complications such as fluid overload or severe dehydration (NIH, 2023).

Other names
Urinary outputDiuresisRenal excretionMicturition output
02

Mechanism of action

Urine excretion is a physiological outcome rather than a molecular target. Therapeutic agents modulate this process by interacting with specific renal molecular targets such as the Na-K-2Cl symporter (NKCC2), the sodium-chloride symporter (NCC), aquaporin channels, or vasopressin receptors to alter the filtration, reabsorption, and secretion of water and solutes (StatPearls, 2023).

03

Biological functions

Excretion of metabolic waste products (e.g., urea, creatinine)Regulation of extracellular fluid volumeElectrolyte homeostasis (sodium, potassium, chloride)Acid-base balanceOsmoregulation
04

Disease associations

HypertensionCongestive heart failureEdemaChronic kidney diseaseDiabetes insipidusSyndrome of inappropriate antidiuretic hormone secretion (SIADH)
05

Safety considerations

Electrolyte imbalances (e.g., hypokalemia, hyponatremia)DehydrationHypovolemiaAcute kidney injuryHypotension
06

Interacting drugs

Furosemide

5 more in the full profile.

07

Biomarkers

Urine volumeUrine osmolalityCreatinine clearanceFractional excretion of sodium (FeNa)Glomerular filtration rate (GFR)

Beyond the preview

Go deeper on Urine excretion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urine excretion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call